Bio-Rad Laboratories | BIO - Себестоимость





Себестоимость Изменить Дата
Abbott USD 5.94B 642M 2026-06
Agilent USD 845M 7M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Bio Techne USD 103.13M 1.47M 2026-03
Bio-Rad Laboratories USD 348M 38.4M 2025-12
Bruker USD 443.6M 84.4M 2026-03
Charles River Laboratories USD 716.51M 5.76M 2026-03
Danaher USD 2.65B 294M 2026-06
General Electric Aerospace USD 8.89B 736M 2026-06
Illumina USD 370M 30M 2026-03
IQVIA Holdings USD 3.08B 161M 2026-03
Laboratory Of America USD 2.6B 4.2M 2026-03
Merck USD 2.94B 380M 2026-03
Mettler Toledo International USD 410.92M 63.05M 2026-03
Myriad Genetics USD 63M 1.1M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Repligen USD 85.97M 8.11M 2026-03
Revvity USD 323.46M 26.93M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Siemens EUR 12.07B 565M 2026-03
Standard Biotools USD 9.84M 2.58M 2026-03
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Tosoh JPY 193.73B 3.46B 2026-03
Waters USD 725M 350.06M 2026-03